Skip to main content
. Author manuscript; available in PMC: 2024 Jun 19.
Published in final edited form as: Ann Surg Oncol. 2022 Aug 4;30(1):165–174. doi: 10.1245/s10434-022-12257-x

FIG. 2.

FIG. 2

Overall survival of matched* patients who underwent resection with or without neoadjuvant chemotherapy for extrahepatic cholangiocarcinoma (A), ampullary adenocarcinoma (B), or duodenal adenocarcinoma (C)